Related Articles
DNA methylation and breast cancer: A way forward (Review)
PD‑L1/PD‑1 blockade in breast cancer: The immunotherapy era (Review)
Triple‑negative breast cancer therapy: Current and future perspectives (Review)
Research progress on immunotherapy in triple‑negative breast cancer (Review)
miRNAs as potential markers for breast cancer and regulators of tumorigenesis and progression (Review)